January 28, 2014
Merck Sharp & Dohme Corp. and Bristol-Myers Squibb Co. have settled a suit against Aurobindo Pharma Ltd. over allegations that Aurobindo tried to introduce a generic version of HIV medication Sustiva before the drug's patents expire, according to a Friday filing in New Jersey federal court.
September 13, 2013
Merck Sharp & Dohme Corp. and Bristol-Myers Squibb Co. sued Aurobindo Pharma Ltd. in New Jersey federal court on Wednesday, alleging the Indian drugmaker is trying to introduce its own version of HIV treatment Sustiva before the drugs' patents expire.